Abstract
The aim of the present study was to evaluate a new anticancer treatment for gastrointestinal cancer, using a combination of polyamine antimetabolites, an anticancer agent and a low-polyamine state. Two polyamine antimetabolites, given as either 40 mg/kg of methylglyoxal-bis-guanylhydrazone (MGBG) or ethylglyoxal-bis-guanylhydrazone (EGBG) and a normal diet (ND), or 20 mg/kg of each drug and a low polyamine diet (LPD), together with 1,000 mg/kg of alpha-difluoromethylornithine (DFMO) were administered ip to nude mice for six consecutive days. Mitomycin C (MMC) at 2 mg/kg was then given ip for 3 alternate days. The combination of MGBG or EGBG with DFMO plus MMC resulted in an enhanced antitumor efficacy on LPD. However, the combination which included EGBG was much more enhanced than that which included MGBG and there was no evidence of any tumor regrowth. Weight loss was minimal or nil in the mice given the combination with EGBG, but was evident in those given the combination with MGBG. These results led to the conclusion that in mice, the combined therapy of EGBG with DFMO plus MMC and LPD is a safe and effective regimen for the treatment of gastric cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Janne J, Poso H, Raina A (1978) Polyamines in rapid growth and cancer. Biochim Biophys Acta 473:241–293
Bloomfield VA, Wilson, RW (1981) Interaction of polyamines with polynucleotides. In: Morris DR (ed) Polyamines in biology and medicine. Marcel Dekker, New York, pp 183–206
Sunkara PS, Chang CC, Prakash NJ, Lachmann PJ (1985) Effect of inhibition of polyamine biosynthesis by DL-α-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo. Cancer Res 45:4067–4070
Raina A, Janne J, Siimes M (1966) Stimulation of polyamine synthesis in relation to nucleic acids in regenerating rat liver. Biochim Biophys Acta 123:197–201
Takami H, Umemoto S, Kodaira S, Ishibiki K, Abe O (1984) Antitumor effect of α-difluoromethylornithine (DFMO) and ornithine decarboxylase activity in human tumor transplanted into nude mice. In: Imahori K, Suzuki F, Suzuki O, Bachrach U (eds) Polyamines: Basic and clinical aspects. VNU Science Press, Utrecht, pp 285–291
Burchenal LH, Lokys L, Smith R, Cartmell S, Warrel P (1981) Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine, stilbamidine and pentamidine in mouse leukemia. Proc Amer Ass Cancer Res 22:230–235
Fujimoto S, Igarashi K, Shrestha RD, Miyazaki M, Okui K (1985) Antitumor effects of two polyamine antimetabolites combined with mitomycin C on human stomach cancer cells xenotransplanted into nude mice. Int J Cancer 35:821–825
Rosenblum MG, Keating MJ, Yap BS, Loo TL (1981) Pharmokinetics of [14C] methylglyoxal-bis(guanylhydrazone) in patients with leukemia. Cancer Res 41:1748–1750
Igarashi K, Porter CW, Morris DR (1984) Comparison of inhibition of polyamine synthesis in bovine lymphocytes by ethylglyoxal bis(guanylhydrazone) and methylglyoxal bis(guanylhydrazone). Cancer Res 44:5326–5331
Ovejera AA, Houchens DP, Barker AD (1978) Chemotherapy of human xenografts in genetically athymic mice. Ann Clin Lab Sci 8:50–56
Brown WO, Badman HG (1961) Liquid-scintillation counting of 14C-labelled animal tissues at high efficiency. Biochem J 78:571–578
Seppanen P, Alhonen-Hongisto L, Janne J (1980) Sensitive enzymic determination of methylglyoxal-bis(guanylhydrazone) in cultured cells and in animal tissue. FEBS Letters 111:99–103
Anehus S, Pohjanpelto P, Baldetorp B, Langstrom E, Heby O (1984) Polyamine starvation prolongs the S and G2 phases of polyamine dependent (arginase-deficient) CHO cells. Mol Cell Biol 4:915–922
Feuerstein B, Porter CW, Dave CA (1979) Selective effect of methylglyoxal-bis(guanylhydrazone) on the synthesis of mitochondrial DNA of cultured L1210 leukemic cells. Cancer Res 39:4130–4137
Herr HW, Kleinert EL, Conti PS, Burchenal JH, Whitemore WF Jr (1984) Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice. Cancer Res 44:4382–4385
Shrestha RD, Fujimoto S, Okui K (1987) Contradictory antitumor efficacies produced by the combination of DNA attacking drugs and polyamine antimetabolites. Jpn J Surg 17:263–267
Fujimoto S, Igarashi K, Shrestha RD, Miyazaki M, Endoh F, Ohta M, Togawa Y, Okui K (1986) Combined therapy of polyamine antimetabolites and antitumor drugs for human gastric cancer xenotransplanted into nude mice. Jpn J Surg 16:133–139
Corti A, Dave C, Williams-Ashman HG, Mihich E, Schenone A (1974) Specific inhibition of the enzymic decarboxylation of S-adenosylmethuonine in methylglyoxal bis(guanylhydrazone) and related substances. Biochem J 139:351–357
Igarashi K, Morris DR (1984) Physiological effects in bovine lymphocytes of inhibiting polyamine synthesis with ethylglyoxal bis(guanylhydrazone). Cancer Res 44:5332–5337
Todd RF, Garnick MB, Canellos GP (1982) Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma. Cancer Treat Rep 66:1585–1586
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shrestha, R.D., Fujimoto, S. & Okui, K. A novel anticancer treatment for xenoplanted human gastric cancer using polyamine antimetabolites in a low polyamine diet. Surg Today 22, 137–142 (1992). https://doi.org/10.1007/BF00311338
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00311338